Back to search

Article

Decitabine induces change of biological traits in myelodysplastic syndromes via FOXO1 activation

2020-08-01

Abstract excerpt

<h4>Background: </h4> Little is known about the function of tumor suppressor gene Forkhead box 1 (FOXO1) in myelodysplastic syndromes (MDS). The aim of this study was to elucidate the role of FOXO1 through decitabine (DAC) treatment. <h4>Methods: </h4>: Microarray analysis was used to identify differentially expressed genes (DEGs) from 2 MDS cell lines by DAC treatment. WebGestalt was used to perform gene ontology...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1425501e-5ca2-5285-815b-e2e5c7f7bb04
DOI
10.21203/rs.3.rs-48006/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Decitabine induces change of biological traits in myelodysplastic syndromes via FOXO1 activationDOI 10.21203/rs.3.rs-48006/v1
Select a neighboring publication to make it the new centre.